Estrella Immunopharma, Inc.
ESLA • NASDAQ
Estrella Immunopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cheng Liu, with a market cap of $78.9M.
Market Cap$78.9M
CEOCheng Liu
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 26, 2026 · in a monthQ1 2026
Financials
ESL
Estrella Immunopharma, Inc. FAQ
Common questions about Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc. is scheduled to report earnings for Q1 2026 on May 26, 2026.